Michael L. King
Director/Board Member at Contraline, Inc.
Profile
Michael L.
King is currently a Director at Contraline, Inc. He was previously a Director at Medivation LLC and a Senior Vice President at Merck & Co., Inc. King holds a graduate degree from the University of Virginia, a doctorate from the University of Delaware, and an undergraduate degree from Virginia Polytechnic Institute & State University.
Michael L. King active positions
Companies | Position | Start |
---|---|---|
Contraline, Inc.
Contraline, Inc. BiotechnologyHealth Technology Contraline, Inc. is a medical device company, which engages in the development of novel hydrogels for reproductive and contraceptive applications. Its Echo-VR product applies hydrogel technology to physically block sperm within the male reproductive tract. The company was founded by Kevin Eisenfrats and John C. Herr in 2015 and is headquartered in Charlottesville, VA. | Director/Board Member | - |
Former positions of Michael L. King
Companies | Position | End |
---|---|---|
MERCK & CO., INC. | Corporate Officer/Principal | - |
MEDIVATION INC | Director/Board Member | - |
Training of Michael L. King
University of Virginia | Graduate Degree |
University of Delaware | Doctorate Degree |
Virginia Polytechnic Institute & State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Private companies | 2 |
---|---|
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Contraline, Inc.
Contraline, Inc. BiotechnologyHealth Technology Contraline, Inc. is a medical device company, which engages in the development of novel hydrogels for reproductive and contraceptive applications. Its Echo-VR product applies hydrogel technology to physically block sperm within the male reproductive tract. The company was founded by Kevin Eisenfrats and John C. Herr in 2015 and is headquartered in Charlottesville, VA. | Health Technology |
- Stock Market
- Insiders
- Michael L. King